| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 487.474 | 468.722 | 490.744 | 481.565 | 219.063 | 0 | 0 | - | - | - |
| Total Income - EUR | 534.322 | 470.729 | 502.132 | 488.367 | 504.214 | 0 | 0 | - | - | - |
| Total Expenses - EUR | 494.500 | 435.859 | 459.928 | 449.769 | 292.518 | 0 | 0 | - | - | - |
| Gross Profit/Loss - EUR | 39.822 | 34.870 | 42.204 | 38.598 | 211.696 | 0 | 0 | - | - | - |
| Net Profit/Loss - EUR | 32.343 | 28.999 | 36.878 | 33.785 | 206.667 | 0 | 0 | - | - | - |
| Employees | 7 | 7 | 8 | 9 | 4 | 0 | 0 | - | - | - |
Check the financial reports for the company - Panaceea Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 30.796 | 26.497 | 24.682 | 22.709 | 0 | 0 | 0 | - | - | - |
| Current Assets | 104.942 | 94.326 | 104.701 | 115.847 | 162.631 | 41 | -5.505 | - | - | - |
| Inventories | 14.238 | 26.272 | 24.704 | 17.174 | -6.904 | 0 | -6.623 | - | - | - |
| Receivables | 42.966 | 24.736 | 65.926 | 94.304 | 168.910 | 0 | 1.030 | - | - | - |
| Cash | 47.738 | 43.319 | 14.071 | 4.370 | 626 | 41 | 88 | - | - | - |
| Shareholders Funds | 37.499 | 29.819 | 37.849 | -21.006 | 162.089 | 41 | 88 | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | - | - | - |
| Debts | 105.407 | 99.931 | 91.533 | 159.562 | 542 | 0 | -5.594 | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Panaceea Pharm Srl